Ursprung des Netzwerks ersten Grades von John Fry
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA.
11
| Extinct | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John Fry
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Alameda County Health Care Services Agency
 Alameda County Health Care Services Agency Medical/Nursing ServicesHealth Services Alameda County Health Care Services Agency provides health care services. The private company is based in San Leandro. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
The San Francisco Aids Foundation
 The San Francisco Aids Foundation Miscellaneous Commercial ServicesCommercial Services The San Francisco Aids Foundation provides education, advocacy, and direct services for HIV prevention and care. The private company is based in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| East Bay AIDS Center | Founder | ||
| GALMED PHARMACEUTICALS LTD. | Pharmaceuticals: Major | Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
Central Health Center
 Central Health Center Medical/Nursing ServicesHealth Services Central Health Center provides healthcare services. The private company is based in Oakland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| National Viral Hepatitis Roundtable | Director/Board Member | ||
| Hepatitis B Foundation | Director/Board Member | ||
| Baruch S. Blumberg Institute | Corporate Officer/Principal | ||
| Berkeley Community Fund | Director/Board Member | ||
Children's Hospital Oakland Research Institute
 Children's Hospital Oakland Research Institute Hospital/Nursing ManagementHealth Services Children's Hospital Oakland Research Institute operates as a biomedical research institute of Children's Hospital and Research Center. The private company is based in Oakland, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Intrivo Diagnostics
 Intrivo Diagnostics Information Technology ServicesTechnology Services Intrivo Diagnostics is a healthcare technology company that provides population health and care solutions through a fully integrated digital health infrastructure. The private company is based in Santa Monica, CA. The CEOs of the company are Ron Gutman and Reeve Benaron. Intrivo is also helping with the fight against COVID-19 by offering at-home testing kits. | Information Technology Services | Director/Board Member | |
| American Liver Foundation of Northern California | Director/Board Member | ||
| A.P. Giannini Foundation | Director/Board Member | ||
| RENOVARO INC. | Biotechnology | Director/Board Member | |
| Pangaea Global Aids | Director/Board Member | ||
| Pure Blue Diagnostics, Inc. | Director/Board Member | ||
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| Institute of Molecular Biology | College/University | Doctorate Degree | |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| PROCEPT BIOROBOTICS CORPORATION | Medical Specialties | Director/Board Member | |
| APOLLO ENDOSURGERY, INC. | Medical Specialties | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal | |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services MacuLogix, Inc. engages in the early detection and tracking of retinal diseases. Its AdaptDx is the first practical measurement tool for dark adaptation which provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma. The company also provides macular degeneration services. The company was founded by John G. Edwards and Gregory R. Jackson in 2004 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member | |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Pharmaceuticals: Major | Director/Board Member | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| Vivo Co-Invest (S) LP | Director/Board Member | ||
Ocelot Bio, Inc.
 Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on improving outcomes for patients with end-stage liver disease (ESLD), particularly those suffering from hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. The company is based in San Diego, CA. The company is developing therapeutic peptides to treat complications of decompensated cirrhosis, a condition in which the liver is scarred and permanently damaged, leading to liver failure. HRS-AKI is a life-threatening consequence of portal hypertension, which causes a significant drop in arterial pressure and renal perfusion. Ocelot Bio is in early-stage development of OCE-205 for the treatment of ascites, a complication of ESLD-induced portal hypertension that leads to the accumulation of fluid in the peritoneal cavity. The company was founded by Geoffrey Harris, and Katherine Vega Stultz has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Dänemark | 4 |
| Israel | 2 |
| Frankreich | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 25 |
| Finance | 6 |
| Health Services | 6 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 106 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 32 |
| Chief Tech/Sci/R&D Officer | 17 |
| Chairman | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Heath Lukatch | 43 |
| Jack Nielsen | 38 |
| Jim Scopa | 26 |
| Carol Brosgart | 25 |
| Bridget Martell | 19 |
| Lawrence Blatt | 13 |
| Kathleen Glaub | 13 |
| Sunny Lee Ryan | 10 |
| Lesley Calhoun | 9 |
| Leonid Beigelman | 8 |
| Rosanne Roth | 7 |
| Lucinda Quan | 5 |
| Matthew McClure | 5 |
| Sushmita M. Chanda | 5 |
| Julian Symons | 4 |
